The board of directors appreciated the support of its shareholders during a period of challenging investment markets.
Zelira Therapeutics Ltd (ASX:ZLD) managing director Dr Richard Hopkins, chairman Osagie Imasogie and clinical trial principal investigator Professor Peter Eastwood, of the University of Western Australia, update Proactive on results from the company’s Phase II clinical trial of medicinal...
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.